Company Filing History:
1 out of 832,912 Years Active: 2014
Title: Göran Larson: Innovator in Alzheimer's Disease Research
Introduction
Göran Larson is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of Alzheimer's disease. His innovative approach focuses on the glycosylation pattern of amyloid-beta peptides, which plays a crucial role in understanding this complex condition.
Latest Patents
Göran Larson holds a patent related to the diagnosis and treatment of Alzheimer's disease. The patent outlines methods for the prevention, treatment, and diagnosis of the disease, emphasizing the importance of analyzing the glycosylation patterns of amyloid-beta peptides found in body fluids and tissues. This groundbreaking work has the potential to enhance the understanding and management of Alzheimer's disease.
Career Highlights
Throughout his career, Göran Larson has dedicated himself to advancing medical research. His innovative ideas and commitment to improving patient outcomes have positioned him as a key figure in the field. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Göran Larson has collaborated with esteemed colleagues such as Jonas A Nilsson and Adnan Fevzi Halim. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Göran Larson's work in Alzheimer's disease research exemplifies the importance of innovation in medicine. His contributions have the potential to change the landscape of diagnosis and treatment for this challenging condition. Through his dedication and collaboration with other experts, he continues to pave the way for future advancements in the field.